Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic Breast Cancer | Zendy

Maren Bredemeier | Zendy; Philippos Edimiris | Zendy; Paweł Mach | Zendy; Mikael Kubista | Zendy; Robert Sjöback | Zendy; Eva Rohlova | Zendy; Katarína Kološtová | Zendy; Siegfried Hauch | Zendy; Bahriye Aktas | Zendy; Mitra Tewes | Zendy; Rainer Kimmig | Zendy; Sabine KasimirBauer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic Breast Cancer

Author(s) -

Maren Bredemeier,

Philippos Edimiris,

Paweł Mach,

Mikael Kubista,

Robert Sjöback,

Eva Rohlova,

Katarína Kološtová,

Siegfried Hauch,

Bahriye Aktas,

Mitra Tewes,

Rainer Kimmig,

Sabine KasimirBauer

Publication year - 2017

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2016.269605

Subject(s) - circulating tumor cell , metastatic breast cancer , cdh1 , medicine , breast cancer , muc1 , cancer research , cancer , oncology , metastasis , biology , cell , cadherin , genetics

Circulating tumor cells (CTCs) are thought to be an ideal surrogate marker to monitor disease progression in metastatic breast cancer (MBC). We investigated the prediction of treatment response in CTCs of MBC patients on the basis of the expression of 46 genes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research